Aprea Therapeutics Financial Overview
Aprea Therapeutics's market cap is currently $5.87M. The company's EPS TTM is $-0.47; its P/E ratio is -0.43; Aprea Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
